Inhibrx Biosciences, Inc. (INBX)

NASDAQ: INBX · Real-Time Price · USD

93.05

-1.15 (-1.22%)

At close: Jun 18, 2026, 4:00 PM EDT

92.80

-0.25 (-0.27%)

After-hours: Jun 18, 2026, 7:19 PM EDT

Inhibrx Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,365	1,152	223	1,800	1,073	1,703
Market Cap Growth	625.43%	416.59%	-87.61%	67.69%	-36.96%	36.95%
Enterprise Value	1,384	1,134	78.38	1,732	1,007	1,649
Last Close Price	93.05	79.00	15.40	38.00	24.64	43.67
PE Ratio	-	-	0.14	-	-	-
PS Ratio	1050.12	885.87	1114.64	1000.02	489.70	235.48
PB Ratio	-	144.08	1.67	41.38	18.49	32.51
P/TBV Ratio	-	153.07	1.73	10.29	17.02	31.69
EV/Sales Ratio	1064.92	872.63	391.91	962.37	459.24	227.99
Debt / Equity Ratio	-8.49	13.10	0.05	4.78	3.54	1.44
Net Debt / Equity Ratio	-0.91	-2.15	-1.08	-1.56	-1.15	-1.03
Net Debt / EBITDA Ratio	-0.16	0.13	0.44	0.31	0.52	0.72
Net Debt / FCF Ratio	-0.15	0.13	0.73	0.34	0.58	0.67
Asset Turnover	0.01	0.01	0.00	0.01	0.01	0.05
Quick Ratio	6.10	3.68	3.76	4.95	9.94	5.89
Current Ratio	6.46	3.93	3.94	5.25	10.17	6.20
Return on Equity (ROE)	1996.40%	-197.85%	1905.92%	-475.31%	-263.00%	-127.91%
Return on Assets (ROA)	-74.48%	-82.52%	-135.66%	-73.22%	-58.51%	-52.05%
Return on Invested Capital (ROIC)	-793.74%	-711.87%	-1813.07%	-1623.52%	-705.98%	-379.76%
Return on Capital Employed (ROCE)	-91.10%	-106.86%	-169.27%	-85.15%	-65.99%	-63.71%
Earnings Yield	-	-	731.30%	-	-	-
Buyback Yield / Dilution	-0.49%	-3.36%	-27.17%	70.62%	-5.52%	-50.47%
Total Shareholder Return	-0.49%	-3.36%	-27.17%	70.62%	-5.52%	-50.47%

SEC Filings: 10-K · 10-Q